C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61P 25/00 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2494008
The present invention relates to altered antibodies to myelin associated glycoprotein (MAG), pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.
L'invention concerne des anticorps modifiés de glycoprotéine associée à la myéline (MAG), des formulations pharmaceutiques contenant ces anticorps et l'utilisation de tels anticorps dans le traitement et/ou la prophylaxie de troubles/maladies neurologiques.
Ellis Jonathan Henry
Germaschewski Volker
Glaxo Group Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Anti-myelin associated glycoprotein (mag) antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-myelin associated glycoprotein (mag) antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-myelin associated glycoprotein (mag) antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1533547